PROVIDENCE - Prospective Non-interventional Study (NIS) to Examine Patient-reported Outcomes and Real-world Clinical Data in Patients With HER2-positive, HER2-low or HER2-ultralow Unresectable or Metastatic Breast Cancer Treated With Trastuzumab Deruxtecan
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
This is a prospective non-interventional, multicenter study observing patient reported outcomes as well as real-world efficacy and safety of trastuzumab deruxtecan (T-DXd) in patients with documented Human epidermal growth factor receptor 2 (HER2)-positive, HER2-low or HER2-ultralow unresectable or metastatic breast cancer (BC) receiving T-DXd in line with the applicable summary of product characteristics (SmPC) within routine clinical practice in Germany. In addition, patients will be informed about use of digital healthcare application (DiGA).
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Osoby w wieku 18 lat i starsze.
- •Pacjentki z rakiem piersi, którego nie można usunąć operacyjnie lub który dał przerzuty.
- •Rak piersi z potwierdzonym statusem HER2+, HER2-low lub HER2-ultralow.
- •Pacjentki, u których stwierdzono postęp choroby pomimo wcześniejszego leczenia.
- •Pacjentki, które kwalifikują się do leczenia Trastuzumabem Derukstekanem zgodnie z jego charakterystyką.
- •Pacjentki rozumiejące język niemiecki lub angielski oraz wyrażające pisemną zgodę na udział w badaniu.
✗ Disqualifies
- •Rozpoczęcie leczenia Trastuzumabem Derukstekanem ponad 30 dni przed włączeniem do badania.
- •Uczulenie na Trastuzumab Derukstekan lub którykolwiek ze składników leku.
- •Ciąża lub karmienie piersią.
- •Obecny lub planowany udział w innym badaniu klinicznym.
- •Obecne lub planowane inne leczenie systemowe dotyczące innych nowotworów niż rak piersi.
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Maximum age
- 130 Years
- Last updated (source)
- July 10, 2026
- Sex
- No restrictions
Locations (108)
Research Site
Amberg, Germany
Research Site
Ansbach, Germany
Research Site
Apolda, Germany
Research Site
Aschaffenburg, Germany
Research Site
Augsburg, Germany
Research Site
Augsburg, Germany
Research Site
Bad Reichenhall, Germany
Research Site
Baden-Baden, Germany
Research Site
Balingen, Germany
Research Site
Bamberg, Germany
Research Site
Berlin, Germany
Research Site
Berlin, Germany
Research Site
Berlin, Germany
Research Site
Berlin, Germany
Research Site
Berlin, Germany
Research Site
Bielefeld, Germany
Research Site
Bonn, Germany
Research Site
Brandenburg an der Havel, Germany
Research Site
Braunschweig, Germany
Research Site
Bremen, Germany
Research Site
Bremerhaven, Germany
Research Site
Coburg, Germany
Research Site
Dessau, Germany
Research Site
Donauwörth, Germany
Research Site
Dortmund, Germany
Research Site
Dresden, Germany
Research Site
Dresden, Germany
Research Site
Düsseldorf, Germany
Research Site
Eggenfelden, Germany
Research Site
Erfurt, Germany
Research Site
Essen, Germany
Research Site
Filderstadt - Bonlanden, Germany
Research Site
Frankfurt, Germany
Research Site
Freudenstadt, Germany
Research Site
Fürstenfeldbruck, Germany
Research Site
Fürstenwalde, Germany
Research Site
Gerlingen, Germany
Research Site
Giessen, Germany
Research Site
Halle, Germany
Research Site
Hamburg, Germany
Research Site
Hamburg, Germany
Research Site
Hanover, Germany
Research Site
Hanover, Germany
Research Site
Hansestadt Salzwedel, Germany
Research Site
Heidenheim, Germany
Research Site
Heilbronn, Germany
Research Site
Hildesheim, Germany
Research Site
Homburg/Saar, Germany
Research Site
Jena, Germany
Research Site
Kaiserslautern, Germany
Research Site
Karlsruhe, Germany
Research Site
Kassel, Germany
Research Site
Kassel, Germany
Research Site
Kempten, Germany
Research Site
Kiel, Germany
Research Site
Krefeld, Germany
Research Site
Kulmbach, Germany
Research Site
Landshut, Germany
Research Site
Leer, Germany
Research Site
Leipzig, Germany
Research Site
Loerrach, Germany
Research Site
Lübeck, Germany
Research Site
Lüneburg, Germany
Research Site
Magdeburg, Germany
Research Site
Mainz, Germany
Research Site
Marburg, Germany
Research Site
Memmingen, Germany
Research Site
Mönchengladbach, Germany
Research Site
Mutlangen, Germany
Research Site
Mühlhausen, Germany
Research Site
München, Germany
Research Site
München, Germany
Research Site
München, Germany
Research Site
Neumarkt, Germany
Research Site
Neustadt am Rübenberge, Germany
Research Site
Nordhausen, Germany
Research Site
Nuremberg, Germany
Research Site
Oldenburg, Germany
Research Site
Oranienburg, Germany
Research Site
Potsdam, Germany
Research Site
Recklinghausen, Germany
Research Site
Regensburg, Germany
Research Site
Rosenheim, Germany
Research Site
Rotenburg (Wümme), Germany
Research Site
Saalfeld, Germany
Research Site
Saarbrücken, Germany
Research Site
Schwäbisch Hall, Germany
Research Site
Siegen, Germany
Research Site
Singen, Germany
Research Site
Solingen, Germany
Research Site
Stade, Germany
Research Site
Stuttgart, Germany
Research Site
Torgau, Germany
Research Site
Troisdorf, Germany
Research Site
Ulm, Germany
Research Site
Ulm, Germany
Research Site
Walsrode, Germany
Research Site
Weiden, Germany
Research Site
Weinheim, Germany
Research Site
Weißenfels, Germany
Research Site
Westerstede, Germany
Research Site
Wiesbaden, Germany
Research Site
Winnenden, Germany
Research Site
Witten, Germany
Research Site
Wolfsburg, Germany
Research Site
Wuppertal, Germany
Research Site
Würzburg, Germany
Research Site
Zittau, Germany
Trial contact
AstraZeneca Clinical Study Information Center
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/1/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.